Elsevier

Clinical Nutrition ESPEN

Volume 23, February 2018, Pages 228-233
Clinical Nutrition ESPEN

Original article
The costs of disease related malnutrition in hospitalized children

https://doi.org/10.1016/j.clnesp.2017.09.009Get rights and content

Summary

Introduction

Disease related malnutrition (DRM) is a serious medical condition which is associated with an increase in morbidity and mortality, augmenting resource use and associated costs. DRM can be detected by actively and fully assessing the nutritional status. Studies in adult malnourished patients have shown that the additional health care costs are about € 2 billion (€ 2000 million) per year. The objective of the current study was to estimate the annual additional costs of DRM for pediatric patients as was done for adults.

Methods

A cost-of-illness analysis was performed to calculate the annual additional costs of DRM in 2015 pediatric patients (aged 1 month up to and including 17 years) admitted to non-academic hospitals in The Netherlands. DRM was assessed with weight-for-age, weight-for-height and height-for-age. Input variables in the formula used were length of stay and prevalence of DRM. The costs were estimated per disease as classified in the International Classification of Diseases by the WHO (ICD-10), per gender and age group. The results were expressed as an absolute monetary value as well as a percentage of the Dutch national health expenditure. Robustness of the results was checked by a sensitivity analysis.

Results

The total additional direct medical costs of DRM in pediatric patients in 2013 were estimated to be € 51 million for acute malnutrition, € 46 million when focused on chronic malnutrition and € 80 million in case of overall malnourished children. This equals 5.6% of the total Dutch hospital costs for these hospitalized children.

Conclusions

This study has shown that DRM in hospitalized children is associated with an increase in annual hospital costs with an additional amount of € 80 million, of which acute malnutrition account for the largest part.

Introduction

Malnutrition is a continuously huge global problem with substantial clinical as well as economic consequences. Despite the fact that the term malnutrition literally comprises both overnutrition (too many nutrients) and undernutrition (too little nutrients), an etiology-related definition of pediatric malnutrition (undernutrition) has been formulated as follows: an imbalance between nutrient requirements and intake that results in cumulative deficits of energy, protein, or micronutrients that may negatively affect growth, development, and other relevant outcomes [1]. Based on its etiology, malnutrition is either illness related (secondary to one or more diseases/injury), non-illness related (caused by environmental/behavioral factors), or both. For the purposes of this article the term malnutrition is used only for the illness related undernutrition, also known as disease related malnutrition (DRM) as only somatically ill children were included.

Although the criteria for defining malnutrition in pediatric patients are used inconsistently, the WHO cut-off measures of <−2 standard deviation scores for weight and/or height compared to age-adjusted references are the most frequently used [2]. These criteria are based on the fact that growth assessment is the best indicator for the nutritional status of a child, as growth (height and weight) is steadily affected by disruption of health and nutrition irrespective of the cause [3]. International studies have shown a DRM prevalence rate in European hospitalized children from 7% up to 45%, with the highest prevalence rate in children with infections, gastro-intestinal disease, mental and behavioral disorders and those with endocrine, nutritional or metabolic diseases [4], [5], [6], [7], [8], [9], [10]. DRM is associated with unfavorable outcomes, including increased rates of infection, increased medical and surgical complications, poor wound healing and increased hospitalization [1], [11]. This association with negative clinical consequences has recently been confirmed in a large multicenter prospective European study, showing DRM was associated with an increased occurrence of diarrhea and vomiting, augmented length of hospital stay (LOS) and a decreased quality of life [4]. Studies in adults have shown that DRM is costing the society billions of euros, leading to an estimated annual cost for European governments of up to € 170 billion (€ 120 billion for EU countries) based on a DRM prevalence rate of 33 million patients (about 20 million in EU countries) [12], [13]. In children however, there is a lack of data about the additional costs due to malnutrition for hospitalized children in Europe, but it is presumed that costs will be substantial [4].

As no cost-of-illness data for malnourished children in The Netherlands exist, the objective of the current study was to calculate the annual additional costs due to DRM for these pediatric patients as was done for adults [14].

Section snippets

Cost-of-illness study

A cost-of-illness analysis has been performed similar to the study that estimated the annual additional costs due to malnutrition in adult patients in The Netherlands [14]. Thus, a total cost per patient group was assessed, in which only hospital costs (direct costs) were used due to lack of data on the indirect costs. Direct health care costs include all costs directly related to the use of care, such as prevention, diagnostics, therapy, rehabilitation and care of the considered disease or

Results

The total additional hospital costs of managing pediatric patients with DRM in 2013 in the age of 1 month up to and including 17 years, were estimated to be € 51 million for acute malnutrition, € 46 million when focused on chronic malnutrition and € 80 million in case of overall malnourished pediatric patients (Table 3). This means that 5.6% of the total Dutch hospital costs for hospitalized children relevant for the patient group in this analysis (€ 1433 million) appear to be related to DRM.

Discussion

To the best of our knowledge, this is the first cost-of-illness study for DRM in hospitalized children in Europe, showing DRM is associated with 40% increase in hospital costs compared to children without suffering from DRM. In the US, hospital costs for children with an ICD coding for malnutrition were calculated to be 3 times higher than those not diagnosed with malnutrition [24] and a study in children under five years old in Thailand showed a 25% increase in hospital costs for malnourished

Statement of authorship

KF and MAK designed the research; KF, EvP and MAK conducted the research, analyzed data and wrote the paper. KJ and JH provided their research data of their follow-up study in Dutch malnourished hospitalized children and critically reviewed and revised the total content of this manuscript where needed. All authors have read and approved the final manuscript.

Conflict of interest

EvP, KJ, JH and MAK have no conflicts of interest. KF receives salary as an employee of Nutricia Advanced Medical Nutrition (NAMN) and is affiliated to the University of Maastricht in The Netherlands. NAMN has an unrestricted agreement with the Maastricht University to enable KF to do research.

Funding sources

This research was funded unrestrictedly by Nutricia Advanced Medical Nutrition (NAMN), The Netherlands; MAK was paid to conduct the analyses as a consultant. The contents of this article are not contingent on approval of NAMN.

References (28)

  • M. Blössner et al.

    Malnutrition: quantifying the health impact at national and local levels

    (2005)
  • K. Huysentruyt et al.

    Hospital-related undernutrition in children: still an often unrecognized and undertreated problem

    Acta Paediatr

    (2013)
  • S. Sissaouia et al.

    Large scale nutritional status assessment in pediatric hospitals

    e-SPEN J

    (2013)
  • L. Restier et al.

    Incorrect evaluation of the frequency of malnutrition and of its screening in hospitalized children by health care professionals

    J Eval Clin Pract

    (2015)
  • Cited by (31)

    • The Nutrition risk profile of 62 408 inpatients based on electronic health records in a tertiary children's hospital

      2021, Nutrition
      Citation Excerpt :

      If pediatric patients had more than one risk factor mentioned above (e.g., preoperation infants with CHD) it was important to perform nutrition risk screening as integrative part of nutrition management from hospital to home. Furthermore, we found an association of higher STAMP scores with more unfavorable clinical outcomes (i.e., longer LOS and higher costs of hospitalization, medication, and antibiotics), which is supported by several previous studies [30–32]. However, regardless of the nutrition screening tools used, few of them focused on large samples.

    • Risk of malnutrition in orthopedic trauma patients with surgical site infections is associated with increased morbidity and mortality – a 3-year follow-up study

      2020, Injury
      Citation Excerpt :

      Previous studies have demonstrated that malnourishment leads to prolonged hospital length of stay [9–11], higher complication rates [12,13], increased mortality [8,9] and higher readmissions rates [10,14]. Furthermore malnourishment contributes to rising healthcare costs [4,15,16]. Several parameters may be used to identify malnourished patients.

    • Impact of Nutritional Deficiencies on Children and Young Adults with Crohn's Disease Undergoing Intraabdominal Surgery

      2020, Journal of Pediatric Surgery
      Citation Excerpt :

      In the general adult surgical population, depression [3], anemia [4], and malnutrition [20] are associated with increased THC, but this has not been explicitly studied within the pediatric CD population. A Dutch study of hospitalized children demonstrated that gastrointestinal disease-related acute and chronic malnutrition were associated with an additional 11% and 9% cost increase respectively [21]. In a U.S. study, pediatric patients with CD undergoing surgery had higher hospital charges by $9758 than nonsurgical pediatric CD patients, but this did not assess for the presence of comorbidities [18].

    View all citing articles on Scopus

    The publication of the study results was not contingent on the sponsor’s approval

    View full text